GSK plc GLAXF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -19.02% | 46.45% | 96.69% | 131.02% | 128.01% |
| Total Depreciation and Amortization | -63.33% | -72.17% | -56.19% | -37.44% | -9.09% |
| Total Amortization of Deferred Charges | 8.28% | 8.28% | 8.28% | 8.28% | 7.16% |
| Total Other Non-Cash Items | 21.13% | 53.74% | 195.39% | 103.98% | 924.27% |
| Change in Net Operating Assets | 116.41% | -0.94% | -1,242.16% | -758.54% | -216.54% |
| Cash from Operations | 16.97% | 11.43% | 20.06% | 22.17% | 8.83% |
| Capital Expenditure | -16.46% | -13.08% | -4.87% | 0.20% | -1.41% |
| Sale of Property, Plant, and Equipment | -33.48% | -26.24% | -19.37% | -61.58% | 573.08% |
| Cash Acquisitions | -459.01% | -265.16% | -173.15% | -113.48% | -134.05% |
| Divestitures | 864.15% | 820.64% | 1,548.03% | -56.85% | -73.25% |
| Other Investing Activities | 77.76% | 57.48% | -3,881.68% | -233.00% | -165.01% |
| Cash from Investing | -153.60% | -36.04% | -114.29% | -248.40% | -3,618.95% |
| Total Debt Issued | 109.44% | -52.08% | -32.15% | 138.18% | 382.68% |
| Total Debt Repaid | 31.77% | 66.94% | 30.48% | 29.42% | -0.43% |
| Issuance of Common Stock | -28.57% | -33.33% | -21.43% | -25.00% | -33.33% |
| Repurchase of Common Stock | 21.24% | -48.89% | -489.47% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -9.41% | -10.86% | -9.60% | -8.32% | -8.63% |
| Other Financing Activities | 22.57% | -16.28% | 18.38% | -12.53% | -44.70% |
| Cash from Financing | 153.11% | -13.60% | -58.30% | 17.15% | 47.55% |
| Foreign Exchange rate Adjustments | -367.82% | 121.85% | 88.16% | 66.09% | 133.10% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 75.40% | -203.07% | -169.84% | -148.12% | -2,699.00% |